Horan Christopher sold $44K of ARTV
Horan Christopher (Chief Tech Operations Officer) sold 10,423 shares of Artiva Biotherapeutics, Inc. (ARTV) at $4.18 on 2026-11-02.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and unlikely to move the stock significantly.
Market read
A small insider sale with limited impact; traders may note but no immediate action required.
What to watch
Potential upcoming clinical data or partnership announcements could offset any minor sell pressure.
Background
Form 4 filings disclose insider transactions; investors monitor them for signals about confidence.
Ticker impact
Chief Tech Operations Officer sold 10,423 shares for $43.6K, reducing his stake to 302,321 shares.
likely slight downward pressure as the market prices the insider sale
The sale is small relative to market cap and does not indicate material concerns, but any insider sell can cause modest short-term weakness.
Market effects
None
None
None
Counterpoint
The sale may be routine and not reflect any negative outlook; the stock could remain stable.
Key entities
- CompanyArtiva Biotherapeutics, Inc.
Biotech firm listed on Nasdaq under ticker ARTV.
- IndividualHoran Christopher
Chief Tech Operations Officer of Artiva Biotherapeutics.



